Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Other Accumulated Expenses (2020 - 2025)

Pulse Biosciences has reported Other Accumulated Expenses over the past 6 years, most recently at $351000.0 for Q3 2025.

  • Quarterly results put Other Accumulated Expenses at $351000.0 for Q3 2025, up 70.39% from a year ago — trailing twelve months through Sep 2025 was $351000.0 (up 70.39% YoY), and the annual figure for FY2024 was $188000.0, changed 0.0%.
  • Other Accumulated Expenses for Q3 2025 was $351000.0 at Pulse Biosciences, up from $212000.0 in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for PLSE hit a ceiling of $815000.0 in Q1 2023 and a floor of $167000.0 in Q2 2024.
  • Median Other Accumulated Expenses over the past 5 years was $251000.0 (2021), compared with a mean of $303222.2.
  • Biggest five-year swings in Other Accumulated Expenses: skyrocketed 176.27% in 2023 and later tumbled 75.83% in 2024.
  • Pulse Biosciences' Other Accumulated Expenses stood at $513000.0 in 2021, then increased by 11.31% to $571000.0 in 2022, then crashed by 67.08% to $188000.0 in 2023, then changed by 0.0% to $188000.0 in 2024, then soared by 86.7% to $351000.0 in 2025.
  • The last three reported values for Other Accumulated Expenses were $351000.0 (Q3 2025), $212000.0 (Q2 2025), and $283000.0 (Q1 2025) per Business Quant data.